Still no green light for Phathom's gastrointestinal drugs after impurities found in batches

Phathom Pharmaceuticals is still working out the kinks of launching two already-approved drugs for a bacterial infection and snagging an NDA approval for another gastrointestinal indication after impurities were found in the first commercial batches.